Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Journal Article (Journal Article;Review)

Genomic medicine has provided new mechanistic understanding for many complex diseases over the last 5-10 years. More recently genomic approaches have been applied to the perioperative paradigm, facilitating identification of patients at high risk for adverse events, as well as those who will respond better/worse to specific pharmacologic therapies. The consistent biological theme emerging is that while inflammation is important in healing from surgical trauma, patients who are too robustly proinflammatory appear to be at higher risk for adverse perioperative events. Precise predictors of each adverse event are being elucidated so that corrective therapeutics can be instituted to improve outcomes in high-risk patients. While the field of perioperative genomics could be considered in its infancy, such approaches are the wave of the future.

Full Text

Duke Authors

Cited Authors

  • Schwinn, DA; Podgoreanu, M

Published Date

  • March 2008

Published In

Volume / Issue

  • 22 / 1

Start / End Page

  • 23 - 37

PubMed ID

  • 18494387

Pubmed Central ID

  • PMC2603024

International Standard Serial Number (ISSN)

  • 1521-6896

Digital Object Identifier (DOI)

  • 10.1016/j.bpa.2007.09.005


  • eng

Conference Location

  • Netherlands